Effects of inhibitors of C1q biosynthesis on macrophage Fc receptor subclass-mediated antibody-dependent cellular cytotoxicity and phagocytosis
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 105 (1) , 127-135
- https://doi.org/10.1016/0008-8749(87)90062-1
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Turbidimetric microassay for macrophage-mediated antibody-dependent cellular cytotoxicityJournal of Immunological Methods, 1986
- Photometric microassay for quantitation of macrophage Fc and C3b receptor functionJournal of Immunological Methods, 1985
- The Classical Complement Pathway: Activation and Regulation of the First Complement ComponentPublished by Elsevier ,1985
- Effects of soluble aggregates of IgG on the binding, uptake and degradation of the Clq subcomponent of complement by adherent guinea pig peritoneal macrophagesEuropean Journal of Immunology, 1985
- Structural Aspects and Heterogeneity of Immunoglobulin Fc ReceptorsPublished by Elsevier ,1981
- Evidence that C1q, a Subcomponent of the First Component of Complement, is an Fc Receptor of Peritoneal and Alveolar MacrophagesImmunobiology, 1980
- The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells.The Journal of Experimental Medicine, 1978
- Reversible inhibition of C1q release from guinea pig macrophages by 2,2′‐dipyridylFEBS Letters, 1978
- C1q production and secretion by fibroblastsNature, 1976
- SYNTHESIS OF THE FIRST COMPONENT OF HUMAN COMPLEMENT IN VITROThe Journal of Experimental Medicine, 1968